Chronic Lymphocytic Leukaemia (CLL) Clinical Trials in Garmisch-Partenkirchen

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project